Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms

Journal of Clinical Oncology

Volumn 24, Issue 24, 2006, Pages 3991-3996

  Sestak, Ivana ^a   Kealy, Roseann ^a   Edwards, Robert ^a   Forbes, John ^a   Cuzick, Jack ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; PLACEBO; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG POTENTIATION; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENSTRUAL IRREGULARITY; NIGHT SWEAT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VASOMOTOR DISORDER; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; ESTROGEN THERAPY; HOSPITALIZATION; MIDDLE AGED; MULTICENTER STUDY; RETROSPECTIVE STUDY; RISK; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; ESTROGEN RECEPTOR MODULATORS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HOT FLASHES; HUMANS; MIDDLE AGED; MULTICENTER STUDIES; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TAMOXIFEN; TREATMENT OUTCOME;

EID: 33748440400     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.3745     Document Type: Article

References (26)

1. Fisher B, Costantino JP, Wickerham DL, et al: Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371-1388, 1998
2. International Breast Cancer Intervention Study Investigators: First results from the International Breast Cancer Intervention Study (IBIS-I): A randomised prevention trial. Lancet 360:817-824, 2002
3. Early Breast Cancer Trialists' Collaborative Group: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
4. Cuzick J, Powles T, Veronesi U, et al: Overview of the main outcome in breast-cancer prevention trials. Lancet 361:296-300, 2003
5. Erlik Y, Meldrum DR, Judd HL: Estrogen levels in postmenopausal women with hot flashes. Obstet Gynecol 59:403-407, 1982
6. Gold EB, Sternfeld B, Kelsey JL, et al: Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 152:463-473, 2000
7. Stearns V, Ullmer L, Lopez JF, et al: Hot flushes. Lancet 360:1851-1861, 2002
8. Freeman EW, Sammel MD, Grisso JA, et al: Hot flashes in the late reproductive years: Risk factors for Africa American and Caucasian women. J Womens Health Gend Based Med 10:67-76, 2001
9. Hays J, Ockene JK, Brunner RL, et al: Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 348:1839-1854, 2003
10. Day R, Ganz P, Costantino JP, et al: Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P1-Study. J Clin Oncol 17:2659-2669, 1999
11. Loprinzi CL, Zahasky KM, Sloan JA, et al: Tamoxifen-induced hot flushes. Clin Breast Cancer 1:52-56, 2000
12. Ockene JK, Barad DH, Cochrane BB, et al: Symptom experience after discontinuing use of estrogen plus progestin. JAMA 294:183-193, 2005
13. Dowsett M, Haynes BP: Hormonal effects of aromatase inhibitors: Focus on premenopausal effects and interaction with tamoxifen. J Steroid Biochem Mol Biol 86:255-263, 2003
14. ATAC Trialists' Group: Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial. Lancet 359:2131-2139, 2002
15. Quella SK, Loprinzi CL, Barton DL, et al: Evaluation of soy phytoestrogens for the treatment of hot flushes in breast cancer survivors: A North Central Treatment Group Trial. J Clin Oncol 18:1068-1074, 2000
16. Loprinzi CL, Sloan JA, Perez EA, et al: Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 20:1578-1583, 2002
17. Quella SK, Loprinzi CL, Sloan JA, et al: Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer 82:1784-1788, 1998
18. Loprinzi CL, Kugler JW, Sloan JA, et al: Venlafaxine in management of hot flushes in survivors of breast cancer: A randomized controlled trial. Lancet 356:2059-2063, 2000
19. Barton D, La VB, Loprinzi CL, et al: Venlafaxine for the control of hot flashes: Results of a longitudinal continuation study. Oncol Nurs Forum 29:33-40, 2002
20. Stearns V, Slack R, Greep N, et al: Paroxetine is an effective treatment for hot flashes: Results from a prospective randomized clinical trial. J Clin Oncol 23:6919-6930, 2005
21. Kimmick GG, Lovato J, McQuellon R, et al: Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. Breast J 12:114-122, 2006
22. Pandya KJ, Morrow GR, Roscoe JA, et al: Gabapentin for hot flashes in 420 women with breast cancer: A randomised double-blind placebo-controlled trial. Lancet 366:818-824, 2005
23. Nelson HD, Vesco KK, Haney E, et al: Non-hormonal therapies for menopausal hot flashes: Systematic review and meta-analysis. JAMA 295: 2057-2071, 2006
24. Stearns V, Johnson MD, Rae JM, et al: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J Natl Cancer Inst 95:1758-1764, 2003
25. Jin Y, Desta Z, Stearns V, et al: CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 97:30-39, 2005
26. Goetz MP, Rae JM, Suman VJ, et al: Pharmocogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flushes. J Clin Oncol 23:9312-9318, 2005